Feature Channels:

Genetics

Add to Favorites | Subscribe | Share

Filters:

  • (Press "esc" to clear)

Medicine

Channels:

Aging, Geriatrics, Mental Health, Psychiatry, Well Being

Researchers Find Common Psychological Traits in Group of Italians Aged 90 to 101

jeste_italy_pirmary.jpg

In remote Italian villages nestled between the Mediterranean Sea and mountains lives a group of several hundred citizens over the age of 90. Researchers at the University of Rome La Sapienza and University of California San Diego School of Medicine have identified common psychological traits in members of this group.

Science

Channels:

Cancer, Imaging, Nanotechnology, Nanoprobes, Biomedical, Health, Medicine, Biomedical Engineering, Magnetic Resonance Imaging, MRI, Breast Cancer, Lesions, Rutgers School of Engineering, Rutgers Cancer Institute of New Jersey, Rutgers Biomedical and Health Sciences, Rutgers University-New Brunswick, cancer imaging, cancer surveillance, cancer tracking, metas

EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 12-Dec-2017 11:00 AM EST

Medicine

Channels:

the Mount Sinai Health System, Icahn School of Medicine at Mount Sinai, sema4, Microbiome, New York University, University Of Florida, Viruses, Genetics

Researchers at Mount Sinai and Sema4 Develop Powerful New Method for Microbiome Analysis

Approach can identify antibiotic resistance and virulence markers missed by conventional techniques

Medicine

Channels:

Pancreatic Cancer, Epigenetics, epithelial-to-mesenchymal transition, PDAC

Researchers Identify Epigenetic Orchestrator of Pancreatic Cancer Cells

Viotti.jpg

Genentech researchers have identified an enzyme that shifts pancreatic cancer cells to a more aggressive, drug-resistant state by epigenetically modifying the cells’ chromatin. The study, which will be published December 11 in the Journal of Cell Biology, suggests that targeting this enzyme could make pancreatic cancer cells more vulnerable to existing therapies that currently have only limited effect against this deadly form of cancer.

Medicine

Channels:

ASH2017, ASH annual meeting, Ash, CAR T, DLBCL, Lymphoma, non-Hodgkin's lymphoma

Global CAR T Therapy Trial Shows High Rates of Durable Remission for Non-Hodgkin’s Lymphoma

In a pair of clinical trials stretching from Philadelphia to Tokyo, the chimeric antigen receptor (CAR) T cell therapy Kymriah™ (formerly known as CTL019) demonstrated long-lasting remissions in non-Hodgkin’s lymphoma (NHL) patients. Results from a global, multisite trial will be presented today at the 59th American Society of Hematology Annual Meeting and Exposition in Atlanta (Abstract #577). Results from the single-site study, with follow-up extending past two years, will be published today in the New England Journal of Medicine.

Medicine

Channels:

Multiple Myeloma, Hematologic Cancers

Sequencing Offers Clues to Progression Toward Multiple Myeloma

Researchers at Dana-Farber Cancer Institute have carried out the largest genomic analysis of patients with smoldering multiple myeloma (SMM), a precursor to full-blown blood cancer that doesn’t show outward symptoms.

Medicine

Channels:

CAR-T cell therapy, Lymphoma

Landmark CAR-T Cancer Study Published in the New England Journal of Medicine

CAR-TInfographic.jpg

Loyola University Medical Center is the only Chicago center that participated in the pivotal clinical trial of a groundbreaking cancer treatment that genetically engineers a patient's immune system to attack cancer cells.

Medicine

Channels:

American Society Of Hematology, Medical Research, Myelofibrosis, genetic-based prediction model

International Research Team Identifies Genetic-Based Model for Predicting Outcomes in Primary Myelofibrosis

A group of investigators from Mayo Clinic and multiple academic research centers in Italy have identified a genetic model for predicting outcomes in patients with primary myelofibrosis who are 70 years or younger and candidates for stem cell transplant to treat their disease.

Medicine

Channels:

breast cancer, , DCE-MRI, dynamic contrast-enhanced magnetic resonance imaging , San Antonio Breast Cancer Symposium, finding small early lesions , psychosocial distress , Mammogram, pathogenic mutations

For Women with Genetic Risk, Bi-Annual MRI Beats Mammograms

Intensive surveillance including a dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) exam every six months was far more effective in detecting breast cancer in younger women with a high-risk genetic profile than an annual mammogram. DCE-MRI every six months performed well for early detection of invasive breast cancer in high-risk women.

Science

Channels:

RNA, rna analysis, Iowa State University, Big Data, big data analytics , Medicine, Genetics, Genome

New Online Database Brings the Genome Into Focus Using Molecular Structure

Structurome_news_release_image.jpg

An online database built by Iowa State University scientists provides a new tool with which researchers can study human biology. The database is freely accessible to anyone on the web, where it allows scientists to study the functions and structure of RNA with greater speed and ease than in the past.







Chat now!